Breaking News Instant updates and real-time market news.

LJPC

La Jolla

$38.44

2.56 (7.13%)

16:01
03/20/17
03/20
16:01
03/20/17
16:01

La Jolla files to sell $100M of common stock

La Jolla intends to use the net proceeds from the underwritten offering for general corporate purposes, including funding its ongoing and future clinical trials of its drug candidates, for expenses relating to the potential regulatory approval of LJPC-501, potential future acquisitions and for general and administrative expenses. J.P. Morgan Securities LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering.

  • 20

    Mar

LJPC La Jolla
$38.44

2.56 (7.13%)

02/27/17
JEFF
02/27/17
NO CHANGE
Target $40
JEFF
Buy
La Jolla price target raised to $40 from $27 at Jefferies
Jefferies analyst Eun Yang raised her price target for La Jolla Pharmaceutical to $40 after the company announced positive top-line results from the Phase 3 study of LJPC-501 in patients with catecholamine resistant hypotension. The stock in afternoon trading is up 82%, or $16.36, to $36.23. While a positive outcome was largely expected, a trend toward mortality benefit is encouraging and unexpected, Yang tells investors in a research note, citing her discussions with experts. Her new price target reflects 100% probability for LJPC-501 clinical success and pricing at parity to other hospital-based drugs. Yang keeps a Buy rating on La Jolla.
02/27/17
COWN
02/27/17
NO CHANGE
Target $55
COWN
Outperform
La Jolla price target raised to $55 from $40 at Cowen
Cowen analyst Phil Nadeau raised La Jolla's price target to $55 from $40 following compelling LJPC-501 data in its SPA-supported Phase III ATHOS-3 trial. The analyst believes the data de-risks LJPC-501 and expects the company to file for FDA approval in 2H 2017. Nadeau has a Buy rating on La Jolla shares.
02/28/17
RHCO
02/28/17
NO CHANGE
RHCO
La Jolla data positive, says SunTrust
SunTrust analyst Yatin Suneja believes that data on La Jolia's LJPC-501 was "highly favorable," supports its approval and suggests that it could become the standard of care in last-line CRH. The analyst thinks that the drug represents an opportunity of at least $500M, and he raised his price target on the name to $57 from $38 while keeping a Buy rating.
03/10/17
CHDN
03/10/17
NO CHANGE
Target $90
CHDN
Buy
Chardan has increased confidence in Top Pick La Jolla
Chardan said it has increased confidence in Top Pick La Jolla Pharmaceutica following meetings wit CEO, George F. Tidmarsh, MD, PhD, while the company was on a roadshow to meet with investors and analysts. The firm's analyst came away from the meeting more positive on the company's de-risked strategy towards drug development, and believes the potential of the strategy is supported by the recent success of LJPC-501 in catecholamine resistant hypotension in its pivotal phase III study, ATHOS-3.

TODAY'S FREE FLY STORIES

FDS

FactSet

$185.76

3.5 (1.92%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Recommendations
FactSet analyst commentary  »

FactSet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOK

Evoke Pharma

$3.44

0.07 (2.08%)

07:39
10/23/17
10/23
07:39
10/23/17
07:39
Hot Stocks
Evoke Pharma announces topline results from comparative exposure PK study »

Evoke Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
JPMorgan to hold a forum »

Japan FinTech Forum is…

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Conference/Events
Piper Jaffray to hold a field trip »

Brazilian Agricultural…

EFX

Equifax

$109.97

-0.54 (-0.49%)

07:38
10/23/17
10/23
07:38
10/23/17
07:38
Downgrade
Equifax rating change  »

Equifax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 14

    Dec

CX

Cemex

$7.96

-0.13 (-1.61%)

07:37
10/23/17
10/23
07:37
10/23/17
07:37
Upgrade
Cemex rating change  »

Cemex upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$56.32

0.32 (0.57%)

, MD

Mednax

07:36
10/23/17
10/23
07:36
10/23/17
07:36
Conference/Events
American Society of Anesthesiology to hold annual meeting »

Anesthesiology 2017…

ABT

Abbott

$56.32

0.32 (0.57%)

MD

Mednax

ABBV

AbbVie

$96.10

-0.38 (-0.39%)

BAX

Baxter

$63.59

0.12 (0.19%)

CAE

CAE

$17.43

0.01 (0.06%)

DDD

3D Systems

$12.00

0.53 (4.62%)

EM

Emdeon

XENE

Xenon Pharmaceuticals

$3.25

0.05 (1.56%)

TRVN

Trevena

$1.76

0.1 (6.02%)

SIEGY

Siemens

$68.33

-1.245 (-1.79%)

NOVA

NovaMed

NUVA

NuVasive

$55.05

0.48 (0.88%)

PFE

Pfizer

$36.42

0.18 (0.50%)

INFI

Infinity Pharmaceuticals

$2.28

-0.12 (-5.00%)

KRO

Kronos Worldwide

$26.17

0.35 (1.36%)

MNK

Mallinckrodt

$32.42

-0.4 (-1.22%)

HAE

Haemonetics

$45.66

0.55 (1.22%)

EW

Edwards Lifesciences

$113.08

1.05 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 27

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 07

    Dec

CMCSA

Comcast

$37.22

0.32 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Recommendations
Comcast analyst commentary  »

Comcast video losses do…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

ENTA

Enanta

$48.16

0.76 (1.60%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Enanta announces 'positive' Phase 1 a/b clinical results for EDP-305 »

Enanta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VZ

Verizon

$49.53

0.32 (0.65%)

, UNP

Union Pacific

$112.99

0.98 (0.87%)

07:35
10/23/17
10/23
07:35
10/23/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

VZ

Verizon

$49.53

0.32 (0.65%)

UNP

Union Pacific

$112.99

0.98 (0.87%)

S

Sprint

$6.93

-0.14 (-1.98%)

PYPL

PayPal

$70.97

3.72 (5.53%)

CTL

CenturyLink

$19.04

0.55 (2.97%)

NSC

Norfolk Southern

$132.75

2.51 (1.93%)

FEYE

FireEye

$16.81

-0.01 (-0.06%)

AMTD

TD Ameritrade

$48.27

0.88 (1.86%)

PRU

Prudential

$110.78

1.18 (1.08%)

AVP

Avon Products

$2.28

0.02 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 29

    Nov

  • 07

    Dec

  • 16

    May

MRK

Merck

$63.88

0.13 (0.20%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.88

0.13 (0.20%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

PFE

Pfizer

$36.42

0.18 (0.50%)

AGN

Allergan

$188.28

-0.99 (-0.52%)

ONCE

Spark Therapeutics

$81.87

1.08 (1.34%)

PODD

Insulet

$61.58

-0.39 (-0.63%)

ACHN

Achillion

$4.15

-0.01 (-0.24%)

SNY

Sanofi

$49.51

-0.51 (-1.02%)

ABEO

Abeona Therapeutics

$19.00

1.25 (7.04%)

JNJ

Johnson & Johnson

$142.40

0.36 (0.25%)

AZN

AstraZeneca

$34.62

-0.09 (-0.26%)

SHPG

Shire

$145.25

-2.57 (-1.74%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

BMY

Bristol-Myers

$64.42

-0.25 (-0.39%)

SCMP

Sucampo

$10.30

0.05 (0.49%)

PCRX

Pacira

$33.50

0.4 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

AAPL

Apple

$156.25

0.27 (0.17%)

07:34
10/23/17
10/23
07:34
10/23/17
07:34
Recommendations
Apple analyst commentary  »

Apple supply/demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
T-Mobile raises low end of postpaid net custuomer adds view to 3.3M-3.6M »

T-Mobile says, "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Hot Stocks
Kimberly-Clark says Q3 a 'challenging environment' »

Chairman and CEO Thomas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

BKS

Barnes & Noble

$7.35

0.15 (2.08%)

07:33
10/23/17
10/23
07:33
10/23/17
07:33
Conference/Events
Barnes & Noble management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
T-Mobile sees FY branded postpaid phone ARPU 'generally stable' to FY16 »

T-Mobile continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

DCPH

Deciphera

$20.15

0.31 (1.56%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Earnings
Kimberly-Clark backs FY17 EPS view at low end of $6.20-$6.35 »

FY17 consensus $6.20. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ZKIN

ZK International Group

$8.23

0.07 (0.86%)

07:32
10/23/17
10/23
07:32
10/23/17
07:32
Hot Stocks
ZK International Group invited by Shenzhen Water Group »

ZK International Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Earnings
T-Mobile reports Q3 EPS 63c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

EGL

Engility

$33.41

-0.11 (-0.33%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Hot Stocks
Engility wins $14M contract from Defense Intelligence Agency »

Engility Holdings won a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 09

    Nov

  • 14

    Dec

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:31
10/23/17
10/23
07:31
10/23/17
07:31
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

DHI

D.R. Horton

$42.67

0.14 (0.33%)

07:30
10/23/17
10/23
07:30
10/23/17
07:30
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.